ArticleFungal systematics and evolution2025
Exploring
Article in Fungal systematics and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Identification ofPathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New blueberry plantings in South Africa have increased dramatically since the year 2000, exceeding the global expansion rate. The crop is, however, impacted by several economically important fungal pathogens. Lesser-known fungi such as pestalotioid species can cause leaf and twig blight, and have the potential to become a global threat to blueberry production and expansion. This study aimed to assess the presence of such fungal species in blueberry nurseries in South Africa due to the industry's exponential growth and mass introduction of new cultivars. Symptomatic leaf and twig samples were collected from six propagation nurseries, resulting in 180 pestalotioid isolates, of which a subset of 48 isolates were selected for molecular characterisation using multi-locus sequence analysis of the internal transcribed spacer region (ITS), partial translation elongation factor 1-α (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.